Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey.

Blagojevic J, Bellando-Randone S, Abignano G, Avouac J, Cometi L, Czirják L, Denton CP, Distler O, Frerix M, Guiducci S, Huscher D, Jaeger VK, Lóránd V, Maurer B, Nihtyanova S, Riemekasten G, Siegert E, Tarner IH, Vettori S, Walker UA, Allanore Y, Müller-Ladner U, Del Galdo F, Matucci-Cerinic M; EUSTAR co-workers.

Arthritis Res Ther. 2019 Jan 24;21(1):35. doi: 10.1186/s13075-019-1822-1.

2.

[Pulmonary fibrosis in rheumatic diseases].

Grund D, Siegert E.

Internist (Berl). 2018 Sep;59(9):911-920. doi: 10.1007/s00108-018-0480-8. Review. German.

PMID:
30094614
3.

Prevalence of sarcopenia in systemic sclerosis: assessing body composition and functional disability in patients with systemic sclerosis.

Siegert E, March C, Otten L, Makowka A, Preis E, Buttgereit F, Riemekasten G, Müller-Werdan U, Norman K.

Nutrition. 2018 Nov;55-56:51-55. doi: 10.1016/j.nut.2018.03.046. Epub 2018 Apr 3.

PMID:
29960157
4.

Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model.

Wu W, Jordan S, Becker MO, Dobrota R, Maurer B, Fretheim H, Ye S, Siegert E, Allanore Y, Hoffmann-Vold AM, Distler O.

Ann Rheum Dis. 2018 Sep;77(9):1326-1332. doi: 10.1136/annrheumdis-2018-213201. Epub 2018 Jun 6.

PMID:
29875097
5.

Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study.

Jaeger VK, Valentini G, Hachulla E, Cozzi F, Distler O, Airó P, Czirják L, Allanore Y, Siegert E, Rosato E, Matucci-Cerinic M, Caimmi C, Henes J, Carreira PE, Smith V, Del Galdo F, Denton CP, Ullman S, De Langhe E, Riccieri V, Alegre-Sancho JJ, Rednic S, Müller-Ladner U, Walker UA; EUSTAR coauthors.

Arthritis Rheumatol. 2018 Nov;70(11):1829-1834. doi: 10.1002/art.40557. Epub 2018 Sep 24.

PMID:
29781588
6.

Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis.

Weigold F, Günther J, Pfeiffenberger M, Cabral-Marques O, Siegert E, Dragun D, Philippe A, Regensburger AK, Recke A, Yu X, Petersen F, Catar R, Biesen R, Hiepe F, Burmester GR, Heidecke H, Riemekasten G.

Arthritis Res Ther. 2018 Mar 22;20(1):52. doi: 10.1186/s13075-018-1545-8.

7.

The impact of malnutrition on quality of life in patients with systemic sclerosis.

Preis E, Franz K, Siegert E, Makowka A, March C, Riemekasten G, Cereda E, Norman K.

Eur J Clin Nutr. 2018 Apr;72(4):504-510. doi: 10.1038/s41430-018-0116-z. Epub 2018 Mar 8.

PMID:
29520082
8.

Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.

Adler S, Huscher D, Siegert E, Allanore Y, Czirják L, DelGaldo F, Denton CP, Distler O, Frerix M, Matucci-Cerinic M, Mueller-Ladner U, Tarner IH, Valentini G, Walker UA, Villiger PM, Riemekasten G; EUSTAR co-workers on behalf of the DeSScipher project research group within the EUSTAR network.

Arthritis Res Ther. 2018 Jan 30;20(1):17. doi: 10.1186/s13075-018-1517-z.

9.

Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.

Jaeger VK, Distler O, Maurer B, Czirják L, Lóránd V, Valentini G, Vettori S, Del Galdo F, Abignano G, Denton C, Nihtyanova S, Allanore Y, Avouac J, Riemekasten G, Siegert E, Huscher D, Matucci-Cerinic M, Guiducci S, Frerix M, Tarner IH, Garay Toth B, Fankhauser B, Umbricht J, Zakharova A, Mihai C, Cozzi F, Yavuz S, Hunzelmann N, Rednic S, Vacca A, Schmeiser T, Riccieri V, García de la Peña Lefebvre P, Gabrielli A, Krummel-Lorenz B, Martinovic D, Ancuta C, Smith V, Müller-Ladner U, Walker UA.

Rheumatology (Oxford). 2018 Mar 1;57(3):441-450. doi: 10.1093/rheumatology/kex182.

PMID:
28499034
10.

Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis.

Beyer C, Huscher D, Ramming A, Bergmann C, Avouac J, Guiducci S, Meier F, Vettori S, Siegert E, Jaeger VK, Maurer B, Riemekasten G, Walker U, Müller-Ladner U, Valentini G, Matucci-Cerinic M, Allanore Y, Distler O, Schett G, Distler JHW.

Ann Rheum Dis. 2018 Apr;77(4):626-628. doi: 10.1136/annrheumdis-2016-210834. Epub 2017 May 11. No abstract available.

PMID:
28495672
11.

The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice.

Siegert E, Paul F, Rothe M, Weylandt KH.

BMC Neurosci. 2017 Jan 24;18(1):19. doi: 10.1186/s12868-016-0312-5.

12.

Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.

Michelfelder M, Becker M, Riedlinger A, Siegert E, Drömann D, Yu X, Petersen F, Riemekasten G.

Clin Rheumatol. 2017 Feb;36(2):381-390. doi: 10.1007/s10067-016-3504-6. Epub 2016 Dec 27.

PMID:
28028682
13.

Digital ulcers score: a scoring system to assess digital ulcers in patients suffering from systemic sclerosis.

Ahrens HC, Siegert E, Tomsitz D, Mattat K, March C, Worm M, Riemekasten G.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):142-147. Epub 2016 Oct 13.

PMID:
27749240
14.

The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index.

Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, Czirják L, Denton CP, Distler O, Hachulla E, Herrick AL, Kowal-Bielecka O, Pope J, Müller-Ladner U, Riemekasten G, Avouac J, Frerix M, Jordan S, Minier T, Siegert E, Ong VH, Vettori S, Allanore Y.

Ann Rheum Dis. 2017 Jan;76(1):270-276. doi: 10.1136/annrheumdis-2016-209768. Epub 2016 Sep 12.

PMID:
27621285
15.

[Pulmonary fibrosis in rheumatic diseases].

Grund D, Siegert E.

Z Rheumatol. 2016 Oct;75(8):795-808. Review. German.

PMID:
27619368
16.

Are we too lenient with immunosuppression in severe cases of Systemic Sclerosis?

Siegert E, Riemekasten G.

Rheumatology (Oxford). 2016 Oct;55(10):1914-6. doi: 10.1093/rheumatology/kew242. Epub 2016 Jun 21. Review. No abstract available.

PMID:
27330162
17.

Monocytic Angiotensin and Endothelin Receptor Imbalance Modulate Secretion of the Profibrotic Chemokine Ligand 18.

Rademacher J, Kill A, Mattat K, Dragun D, Siegert E, Günther J, Riemekasten G.

J Rheumatol. 2016 Mar;43(3):587-91. doi: 10.3899/jrheum.150474. Epub 2016 Jan 15.

PMID:
26773103
18.

Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients.

Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, Melchers I, Mueller-Ladner U, Frerix M, Kreuter A, Tigges C, Lahner N, Susok L, Guenther C, Zeidler G, Pfeiffer C, Worm M, Karrer S, Aberer E, Bretterklieber A, Genth E, Simon JC, Distler JH, Hein R, Schneider M, Seitz CS, Herink C, Steinbrink K, Sárdy M, Varga R, Mensing H, Mensing C, Lehmann P, Neeck G, Fiehn C, Weber M, Goebeler M, Burkhardt H, Buslau M, Ahmadi-Simab K, Himsel A, Juche A, Koetter I, Kuhn A, Sticherling M, Hellmich M, Kuhr K, Krieg T, Ehrchen J, Sunderkoetter C, Hunzelmann N; German Network for Systemic Scleroderma.

J Rheumatol. 2016 Jan;43(1):66-74. doi: 10.3899/jrheum.150382. Epub 2015 Nov 15.

19.

Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus.

von Spee-Mayer C, Siegert E, Abdirama D, Rose A, Klaus A, Alexander T, Enghard P, Sawitzki B, Hiepe F, Radbruch A, Burmester GR, Riemekasten G, Humrich JY.

Ann Rheum Dis. 2016 Jul;75(7):1407-15. doi: 10.1136/annrheumdis-2015-207776. Epub 2015 Aug 31.

PMID:
26324847
20.

Functional autoantibodies in systemic sclerosis.

Günther J, Rademacher J, van Laar JM, Siegert E, Riemekasten G.

Semin Immunopathol. 2015 Sep;37(5):529-42. doi: 10.1007/s00281-015-0513-5. Epub 2015 Aug 21. Review.

PMID:
26292621
21.

Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE.

Humrich JY, von Spee-Mayer C, Siegert E, Alexander T, Hiepe F, Radbruch A, Burmester GR, Riemekasten G.

Ann Rheum Dis. 2015 Apr;74(4):791-2. doi: 10.1136/annrheumdis-2014-206506. Epub 2015 Jan 21. No abstract available.

PMID:
25609413
22.

[Sex-specific differences of the immune system].

Riemekasten G, Siegert E.

Z Rheumatol. 2014 Sep;73(7):600-6. doi: 10.1007/s00393-014-1357-4. Review. German.

PMID:
25098690
23.

Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients.

Günther J, Kill A, Becker MO, Heidecke H, Rademacher J, Siegert E, Radić M, Burmester GR, Dragun D, Riemekasten G.

Arthritis Res Ther. 2014 Mar 11;16(2):R65. doi: 10.1186/ar4503.

24.

Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples.

Gomolka B, Siegert E, Blossey K, Schunck WH, Rothe M, Weylandt KH.

Prostaglandins Other Lipid Mediat. 2011 Apr;94(3-4):81-7. doi: 10.1016/j.prostaglandins.2010.12.006. Epub 2011 Jan 12.

PMID:
21236358
25.

Sirt1 contributes critically to the redox-dependent fate of neural progenitors.

Prozorovski T, Schulze-Topphoff U, Glumm R, Baumgart J, Schröter F, Ninnemann O, Siegert E, Bendix I, Brüstle O, Nitsch R, Zipp F, Aktas O.

Nat Cell Biol. 2008 Apr;10(4):385-94. doi: 10.1038/ncb1700. Epub 2008 Mar 16.

PMID:
18344989
26.

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.

Straus SE, Jaffe ES, Puck JM, Dale JK, Elkon KB, Rösen-Wolff A, Peters AM, Sneller MC, Hallahan CW, Wang J, Fischer RE, Jackson CE, Lin AY, Bäumler C, Siegert E, Marx A, Vaishnaw AK, Grodzicky T, Fleisher TA, Lenardo MJ.

Blood. 2001 Jul 1;98(1):194-200.

27.

Shift of aberrant antigen expression at relapse or at treatment failure in acute leukemia.

Oelschlägel U, Nowak R, Schaub A, Köppel C, Herbst R, Mohr B, Löffler C, Range U, Günther H, Assmann M, Siegert E, Wendt E, Huhn R, Bräutigam E, Ehninger G.

Cytometry. 2000 Aug 15;42(4):247-53.

PMID:
10934344
28.

Clinical importance of prothrombotic risk factors in pediatric patients with malignancy--impact of central venous lines.

Knöfler R, Siegert E, Lauterbach I, Taut-Sack H, Siegert G, Gehrisch S, Müller D, Rupprecht E, Kabus M.

Eur J Pediatr. 1999 Dec;158 Suppl 3:S147-50.

PMID:
10650856
29.

[Nurses ensure the care for children of mentally ill parents. Children and the parent role of the patient].

Siegert E.

TVZ. 1998 Feb 14;108(3):82-3. Dutch. No abstract available.

PMID:
9534623
30.

Non-Hodgkin lymphoma (NHL) as a second neoplasm occurring after neuroblastoma treatment.

Siegert E, Weissbach G, Fischer R, Lauterbach I.

Med Pediatr Oncol. 1998 Jan;30(1):18-21.

PMID:
9371384
31.

Tube feeding preferences among nursing home residents.

O'Brien LA, Siegert EA, Grisso JA, Maislin GM, LaPann K, Evans LK, Krotki KP.

J Gen Intern Med. 1997 Jun;12(6):364-71.

32.

Impact of advance directive videotape on patient comprehension and treatment preferences.

Siegert EA, Clipp EC, Mulhausen P, Kochersberger G.

Arch Fam Med. 1996 Apr;5(4):207-12.

PMID:
8769908
33.

Nursing home residents' preferences for life-sustaining treatments.

O'Brien LA, Grisso JA, Maislin G, LaPann K, Krotki KP, Greco PJ, Siegert EA, Evans LK.

JAMA. 1995 Dec 13;274(22):1775-9.

PMID:
7500508
34.

Prolonged thrombocytopenia associated with procainamide in an elderly patient.

Landrum EM, Siegert EA, Hanlon JT, Currie MS.

Ann Pharmacother. 1994 Oct;28(10):1172-6. Review.

PMID:
7841573
35.

[Encephalopathy in leukemia treatment in children].

Siegert E, Lauterbach I, Weissbach G, Tellkamp H.

Monatsschr Kinderheilkd. 1991 Jun;139(6):368-70. German.

PMID:
1896052
36.

[Thrombocytopenia after autologous bone marrow transplantation in in acute lymphatic leukemia].

Siegert E, Lauterbach I, Weissbach G.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1990;117(2):265-70. German.

PMID:
1697828
37.
38.

[A rare cause of hematuria: parahemophilia].

Siegert E, Quietzsch J.

Kinderarztl Prax. 1984 Jul;52(7):344-6. German. No abstract available.

PMID:
6482184
39.

[Homozygotic Pelger-Huet anomaly].

Siegert E, Beier L, Gräbner H.

Kinderarztl Prax. 1983 Apr;51(4):164-9. German. No abstract available.

PMID:
6887704
40.

[Corticoid myopathy].

Siegert E.

Kinderarztl Prax. 1981 Mar;49(3):157-60. German. No abstract available.

PMID:
7230626
41.

[Corticoid myopathy in children].

Siegert E, Häntzschel HJ, Dietel K, Voigt W.

Acta Paediatr Acad Sci Hung. 1981;22(3):211-5. German. No abstract available.

PMID:
6272538
42.

[Cholangitis in mucoviscidosis].

Günther J, Quietzsch J, Siegert E, Frey G.

Kinderarztl Prax. 1980 Sep;48(9):488-92. German. No abstract available.

PMID:
7431743
43.

[Multilobular biliary liver cirrhosis as a purely hepatic form of mucoviscidosis].

Quietzsch J, Siegert E, Günther J.

Dtsch Z Verdau Stoffwechselkr. 1979;37(4):183-9. German.

PMID:
540564
44.

[Fanconi's anemia].

Siegert E.

Kinderarztl Prax. 1974 Jun;42(6):257-61. German. No abstract available.

PMID:
4431170
45.

[Intoxication caused by Kolton-gelee in three children].

Siegert E.

Kinderarztl Prax. 1971 Dec;39(12):557-61. German. No abstract available.

PMID:
4400914
46.

[Clinical morphologic and therapeutic viewpoints on neoplastic reticulosis in childhood].

Hempel HC, Grimm J, Siegert E.

Monatsschr Kinderheilkd. 1968 Nov;116(11):588-93. German. No abstract available.

PMID:
5728543

Supplemental Content

Loading ...
Support Center